The Use of Artificial Intelligence in New Normal Era Against Pandemic COVID-19 in the Field of Health Services
Downloads
Background: Indonesia is currently experiencing Coronavirus Disease-19 (COVID-19) pandemic which affects all sectors of life, therefore Indonesia is starting to prepare for New Normal era, including in health care sector. COVID-19 was previously known as novel Coronavirus Disease-19 (nCoV-19), where World Health Organization (WHO) declared it as a global pandemic in March 2020. New Normal era is an era of coexistence with COVID-19, resulting in new habits that were rarely or never practiced before. One practice that can be applied in health care sector is to use Artificial Intelligence (AI) to treat COVID-19 patients to prevent casualties for health workers. Health care providers are prone to contract aerosol and droplet transmission while treating patients, resulting in cytokine storm, acute respiratory distress syndrome (ARDS), and acute lung injury (ALI), which leads to death. Purpose: This mini review study used to explain the using of artificial intelligence in the new normal era against pandemic COVID-19 in the field of health services. Reviews: This pandemic COVID-19 restricts all of the communication between person to person. It also challenged the health service sector because the health service sector is the first line to combat the COVID-19. It is now popular to use artificial intelligence. This using can be used to help the health service sector in combating the COVID-19 pandemic especially in this new normal era. Conclusion: COVID-19 pandemic affects all aspects of life, especially health care sector, therefore AI use is important to prevent the deaths of health workers because of this pandemic.
Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. Journal of Pharmaceutical Analysis.2020: 1-17; doi: https:/doi.org/10.1016/j.jpha.2020.03.001
Mourya DT, Sapkal G, Yadav PD, Belani SKM, Shete A, Gupta N. Biorisk assessment for infrastructure & biosafety requirements for the laboratories providing coronavirus SARS-CoV-2/(COVID-19) diagnosis. Indian J Med Res. 2020; 151:172-176
Meng L, Hua F, Bian Z. Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for Dental and Oral Medicine. Journal of Dental Research. 2020: 1-7; DOI: 10.1177/0022034520914246journals.sagepub.com/home/jdr
Bhatia R, Chaudary R, Khurana SK, Tiwari R, Dhama K, Gupta VK, et al. Strengthening og Molecular Diagnosis of SARS-CoV-2 / COVID-19 with a Special Focus in India. J Pure Appl Microbiol; 14(1):789-798
Susilo A, Rumende CM, Piloyo CW, Santoso WD, Yulianti M, Herikurniawan, et al. Coronavirus Disease 2019: Tinjauan Literatur Terkini. Jurnal Penyakit Dalam Indonesia. 2020;7(1): 45-67; DOI: http://dx.doi.org/10.7454/jpdi.v7i1.415
Ciotti M, Angeletti S, Minieri M, Giovanetti M, Benvenuto D, Pascarella S, et al. COVID-19 Outbreak: An Overview. 2020. Chemotherapy: 1-9; DOI: 10.1159/000507423
Wikipedia. COVID-19 pandemic data. 2020. https://en.wikipedia.org/wiki/Template:COVID-19_pandemic_data (Accessed: 28 June 2020)
Kementerian Kesehatan Indonesia. Dashboard kasus COVID-19 di Indonesia. 2020. Available from: https://www.kemkes.go.id/article/view/20031900002/Dashboard-Data-Kasus-COVID-19-di-Indonesia.html. Accessed 2020 July 6.
Dinas Kesehatan Kota Jakarta. Data pantauan COVID-19 Jakarta. 2020. Available from: https://corona.jakarta.go.id/id. Accessed 2020 July 6.
Zhou Y, Fu B, Zheng X, Wang D, Zhao C, et al. Pathogenic T Cells and inflammatory monocytes incite inflammatory storm in secere COVID-19 patients. Downloaded from https://academic.oup.com/nsr/advance-article-bstract/doi/10.1093/nsr/nwaa041/5804736 by Kangwon National University, Samcheok Campus user on 21 March 2020
Keputusan Menteri Kesehatan Republik Indonesia No. HK.01.07/MENKES/413/2020 2020 Pedoman Pencegahan dan Pengendalian Coronavirus Disease-19 (COVID-19)
Jayaweera M, Perera H, Gunawardana B, Manatunge J. Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy. 2020;Environt Res; 188: 1-19
Hudoyono R, Bramantoro T, Benyamin B, Dwiandhono I, Soesilawati P, Hudyono AP, et al. During and post COVID-19 pandemic: prevention of cross infection at dental practices in country with tropical climate. 2020; Dent J MKG; 53(2):108-114
Perez JA, Deligianni F, Ravi D, and Yang GZ. Artificial Intelligence and Robotics. 2017. UK-RAS Network Robotics and Autonomous Systems UKRAS.ORG
Dananjayan S, Raj GM. Artificial Intelligence during a pandemic: The COVID-19 example. Int J Health Plann Mgmt. 2020:1-3; DOI: 10.1002/hpm.2987
Faiq MA, Kumar A, Singh HN, Pareek V, Qadri R, Raza K, et al. COVID-19: A review on molecular basis, pathogenic mechanisms, therapeutic aspencts and future projections. Preprints. 2020;1:1-29. DOI:10.20944/preprints202004.0091.v1
World Health 2020 Organization Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations.
Reid J 2020 Deutsche Bank Research konzept (Deutsche: Deutshce Bank Research)
Setiawan FS, Yudianto A, Mooduto L, Sunariani J. New Normal to Achieve High Treshold Herd Immunity by (Ro and Pc) Post Pandemic COVID-19. Malaysian Journal of Medicine and Health Sciences. 2021; 17 (2): 141-145
Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. JARE. 2020; 24: 1-8, https://doi.org/10.1016/j.jare.2020.03.005
Turista DDR, Islamy A, Kharisma VD, Ansori ANM. Distribution of COVID-19 and Phylogenetic Tree Construction of SARS-CoV-2 in Indonesia. J Pure Appl Microbiol. 2020; 14(1):1035-1042; https://doi.org/10.22207/JPAM.14.SPL1.42
Sahin AR, Erdogan A, Agaoglu PM, Dineri Y, Cakirci AY, et al. Review: 2019 Novel Coronavirus (COVID-19) Outbreak: A Review of the Current Literature. EJMO. 2020;4(1): 1-7; DOI: 10.14744/ejmo.2020.1220
Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Military Medical Research. 2020; 7(1): 1-10; https://doi.org/10.1186/s40779-020-00240-0
Suprobowati OD, Kurniati I. Bahan Ajar Teknologi Laboratorium Medik (LTM) Virologi. Kementerian Kesehatan Republik Indonesia Pusat Pendidikan Sumber Daya Manusia Kesehatan. 2018. Available at: http://bppsdmk.kemkes.go.id/pusdiksdmk/wp-content/uploads/2018/09/Virologi_SC.pdf. (Accessed at 28 June 2020)
World Health Organization. 2020. Infection Prevention and Control for the safe management of a dead body in the context of COVID-19. Available at: https://apps.who.int/iris/bitstream/handle/10665/331538/WHO-COVID-19-lPC_DBMgmt-2020.1-eng.pdf (Accessed: 11 April 2020)
The Royal College of Pathologists. (2020) Transmission-based precautions Guidance for care of deceased during COVID-19 pandemic. Available at: https://www.rcpath.org/uploads/assets/0b7d77fa-b385-4c60-b47dde930477494b/G200-TBPs-Guidance-for-care-of-deceased-during-COVID-19-pandemic.pdf (Accesed: 11 April 2020)
Dietz L, Horve PF, Coil D, Fretz M, Eisen J, et al. 2019 Novel Coronavirus (COVID-19) Outbreak: A Review of the Current Literature and Built Environment Considerations to Reduce Transmission. Preprints. 2020: 1-35; doi: 10.20944/ preprints202003.0197.v2
Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, et al. Aerosol and Surface Stability of SARS-CoV 2 as Compared with SARS-CoV 1. The New England Journal of Medicine. 2020: 1-3; DOI: 10.1056/NEJMc2004973
Blocken B, Malizia F, Druenen Tv, Marchal T 2020 Towards aerodinamically equivalent COVID-19 1.5 m social distancing for walking and running
Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, Li TW, Chen Q. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of mucosa. Nature Publishing Group. 2020; 12 (1):1-5. doi: 10.1038/s41368-020-0074-x
Aljerian K, BaHammam AS. COVID-19: Lessons in laboratory medicine, pathology, and autopsy. Ann Thorac Med. 2020, 15:138-145, DOI: 10.4103/atmATM_173_20
Tai W, He L, Zhang X, Pu J, Voronin D, et al. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as viral attachment inhibitor and vaccine. Nature: Cellular & Molecular Immunology. 2020: 1-8 Downloaded from https://www.nature.com/articles/s41423-020-0400-4.pdf, on 22 June 2020
Hoffman M, Weber HK, Schroeder S, Kruger N, Herrler T, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell Press. 2020; 181: 1-10; https://doi.org/10.1016/j.cell.2020.02.052
Setiawan F, Puspitasari H, Sunariani J, Yudianto A. Molecular Review COVID-19 From The Pathogenesis and Transimission Aspect. Jurnal Kesehatan Lingkungan. 2020; 12(1); DOI: 10.20473/jkl.vl12ilsi.2020.94-104
Lau SKP, Chan JFW. Coronaviruses: emerging and re-emerging pathogens in humans and animals. Virology Journal. 2015; 12: 1-3https://doi.org/10.1186/s12985-015-0432-z
Fu Y, Cheng Y, Wu Y. Understanding SARS-CoV-2 Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools. Virology Sinica. 2020: 1-6; https://doi.org/10.1007/s12250-020-00207-4
Liu J, Li S, Liu J, Liang B, Wang X, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV 2 infected patients. 2020: 1-35; https://doi.org/10.1101/2020.02.16.20023671
Sun Q, Qiu H, Huang M, Yang Y. Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province. Ann Intensive Care. 2020; Vol. 10:1-4; https://doi.org/10.1186/s13613-020-00650-2
Gardezi SAH, Ikram A. Application of Biosafety Principles in Laboratory Analysis of Clinical Samples from Patients with COVID-19. J Pak Med Assoc. 2020; 70(5):1-4; DOI: https://doi.org/10.5455/JPMA.10
Bruin YB, Lequarre AS, McCourt J, Clevestig P, Pigazzani F, Jeddi MZ, et al. Initial impacts of global risk mitigation measures taken during the combatting of the COVID-19 pandemic. Safety Science. 2020; 128:1-8; https://doi.org/10.1016/j.ssci.2020.104773
Chen CC, Chi CY. Biosafety in the Preparation and Processing of Cytology Specimens With Potential Coronavirus (COVID-19) Infection: Perspectives From Taiwan. Cancer Cytopathology. 2020:309-316; DOI: 10.1002/cncy.2280
Tripathi M, Kumar S. Epidemiology, Treatment and Microbiological Surveillance of SARS-CoV-2. Ann Resc & Rev in Biol. 2020; 35(5); 114-121; DOI: 10.9734/ARRB2020/v35i530230
Kricka LJ, Poleikov S, Park JY, Fortina P, Bernerdini S, Satchkov D, et al. Artificial Intelligence-powered search tools and resources in the fight against COVID-19. eJIFCC. 2020; 31(2):106-116
Nguyen TT. Artificial Intelligence in the Battle against Coronavirus (COVID-19): A Survey and Future Research Directions. Preprints. 2020: 1-13; DOI:10.13140/RG.2.2.36491.23846
Malone B, Simovski B, Moline C, Cheng J, Gheorghe M, Fontenelle H, et al. Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2: toward universal blueprints for vaccine designs. 2020: 1-35; doi: https//doi.org/10.1101/2020.04.21.052084
Naude W. Artificial Intelligence vs COVID-19: limitations, constratins, and pitfalls. AI & Society. 2020: 1-5; https://doi.org/10.1007/s00146-20-00978-0
McCall B. COVID-19 and artificial intelligence; protecting health-care workers and curbing the spread. Lancet. 2020; 395:e30-e31; DOI: 10.1128/VI.00127-20
Zein A. Pendeteksian Virus Corona Dalam Gambar X-Ray Menggunakan Algoritma Artificial Intelligence dengan Deep Learning Python. J Tekn Infor ESIT. 2020; XV(01):19-23
Vaishya R, Javaid M, Khan IH, Hallem A. Artificial Intelligence (AI) applications for COVID-19 pandemic. Diabet & Metabol Synd: Clin Resc & Rev. 2020; 14:337-339; https://doi.org/10.1016/j.dsx.2020.04.012
This work is licensed under a Creative Commons Attribution 4.0 International License.
CDJ by Unair is licensed under a Creative Commons Attribution 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions
